IRadimed Corporation
IRMDNASDAQNASDAQ Capital Market·USD·Closed
$97.88
−$1.30 (1.31%)
$97.88
−$1.30 (1.31%)
Not investment advice.Learn more
IRadimed Corporation leans slightly positive on balance, but risks remain.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Near 52-week high
Volume
Market Cap
Small-cap company
P/E Ratio
Investors paying a premium
Div Yield
Pays a modest dividend